Sarepta Therapeutics Stock Forecast
Weaker technical forecast for Sarepta Therapeutics as stock downgraded to Sell Candidate.
(Updated on Apr 18, 2024)
The Sarepta Therapeutics stock price fell by -1.14% on the last day (Thursday, 18th Apr 2024) from $117.89 to $116.55. During the last trading day the stock fluctuated 2.69% from a day low at $115.79 to a day high of $118.90. The price has fallen in 6 of the last 10 days and is down by -7.35% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -112 thousand shares and in total, 413 thousand shares were bought and sold for approximately $48.11 million.
The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $116.20 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Sarepta Therapeutics stock with a 90% probability to be traded between $116.65 and $142.41 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
SRPT Signals & Forecast
There are few to no technical positive signals at the moment. The Sarepta Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $120.52 and $124.42. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -17.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Sarepta Therapeutics stock
Sarepta Therapeutics finds support from accumulated volume at $115.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.11 between high and low, or 2.69%. For the last week, the stock has had daily average volatility of 2.81%.
Sarepta Therapeutics is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (SRPT) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Sarepta Therapeutics to open at $117.08, and during the day (based on 14 day Average True Range), to move between $113.18 and $119.92, which gives a possible trading interval of +/-$3.37 (+/-2.89%) up or down from last closing price. If Sarepta Therapeutics takes out the full calculated possible swing range there will be an estimated 5.78% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $115.64 (0.78%) than the resistance at $127.90 (9.74%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Sarepta Therapeutics stock A Buy?
Sarepta Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -1.083 Sell Candidate Downgraded
Predicted Opening Price for Sarepta Therapeutics of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $117.08 ( 0.455%) | $116.55 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for SRPT
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 120.19 | 3.12 % | |
| R2 | 119.00 | 2.10 % | ||
| R1 | 118.27 | 1.47 % | ||
| Current price: | 116.55 | |||
| Support | S1 | 115.89 | -0.565 % | |
| S2 | 115.16 | -1.19 % | ||
| S3 | 113.97 | -2.21 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 134.61 | 15.50 % | |
| R2 | 128.67 | 10.40 % | ||
| R1 | 127.90 | 9.74 % | ||
| Current price | 116.55 | |||
| Support | S1 | 115.64 | -0.781% | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Sarepta Therapeutics Stock.
